In the new Agentic Commercial model for life sciences, agentic AI compliantly delivers Commercial Evidence to identify exactly what patients and HCPs care about. Pharmaceutical Executive: What is Commercial Evidence and why is it a critical opportunity for Commercial and Brand teams? Matt Farrell: It’s an Agentic AI breakthrough that enables biopharmas to get the complete picture of what’s happening with HCP engagement, whether in-person or digital channels. We’ve seen that using Commercial Evidence can accelerate launch performance by more than 10%, a critical impact for the trajectory of a new brand. Having an agentic commercial path to uncover and address treatment barriers is a big step to accelerate performance and drive outcomes.